Orthofix Medical Inc. Operating Income
Orthofix Medical Inc. (OFIX) reported Operating Income of -$8.13 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-05
- Orthofix Medical Inc. operating income (loss) for the quarter ending 2026-06-30 was -$8.13M.
- Orthofix Medical Inc. operating income (loss) for the quarter ending 2026-03-31 was -$14.44M.
- Orthofix Medical Inc. operating income (loss) for the quarter ending 2025-12-31 was $494.00K.
- Orthofix Medical Inc. operating income (loss) for the quarter ending 2025-09-30 was -$17.05M.
- Orthofix Medical Inc. operating income (loss) for fiscal 2025 was -$81.43M.
- Orthofix Medical Inc. operating income (loss) for fiscal 2024 was -$84.62M.
- Orthofix Medical Inc. operating income (loss) for fiscal 2023 was -$139.11M.
- Orthofix Medical Inc. operating income (loss) for fiscal 2022 was -$13.27M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$8.13M 10-Q · filed 2026-08-05 | -$22.57M 10-Q · filed 2026-08-05 | -$22.08M derived: sum of 3 quarters · filed 2026-08-05 | -$39.12M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$14.44M 10-Q · filed 2026-05-05 | -$13.94M derived: sum of 2 quarters · filed 2026-05-05 | -$30.99M derived: sum of 3 quarters · filed 2026-05-05 | -$46.99M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-12-31 | $494.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$16.55M derived: sum of 2 quarters · filed 2026-02-24 | -$32.55M derived: sum of 3 quarters · filed 2026-08-05 | -$81.43M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | -$17.05M 10-Q · filed 2025-11-04 | -$33.05M derived: sum of 2 quarters · filed 2026-08-05 | -$81.92M 10-Q · filed 2025-11-04 | -$93.40M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-06-30 | -$16.00M 10-Q · filed 2026-08-05 | -$64.88M 10-Q · filed 2026-08-05 | -$76.35M derived: sum of 3 quarters · filed 2026-08-05 | -$95.25M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2025-03-31 | -$48.87M 10-Q · filed 2026-05-05 | -$60.35M derived: sum of 2 quarters · filed 2026-05-05 | -$79.25M derived: sum of 3 quarters · filed 2026-05-05 | -$104.16M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$11.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$30.38M derived: sum of 2 quarters · filed 2026-02-24 | -$55.28M derived: sum of 3 quarters · filed 2026-02-24 | -$84.62M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | -$18.90M 10-Q · filed 2025-11-04 | -$43.80M derived: sum of 2 quarters · filed 2025-11-04 | -$73.14M 10-Q · filed 2025-11-04 | -$91.46M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | -$24.91M 10-Q · filed 2025-08-05 | -$54.24M 10-Q · filed 2025-08-05 | -$72.56M derived: sum of 3 quarters · filed 2026-02-24 | -$97.01M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | -$29.34M 10-Q · filed 2025-05-06 | -$47.65M derived: sum of 2 quarters · filed 2026-02-24 | -$72.10M derived: sum of 3 quarters · filed 2026-02-24 | -$108.73M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | -$18.32M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$42.76M derived: sum of 2 quarters · filed 2026-02-24 | -$79.40M derived: sum of 3 quarters · filed 2026-02-24 | -$139.11M 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | -$24.45M 10-Q · filed 2024-11-07 | -$61.08M derived: sum of 2 quarters · filed 2024-11-07 | -$120.80M 10-Q · filed 2024-11-07 | -$131.84M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | -$36.63M 10-Q · filed 2024-08-06 | -$96.35M 10-Q · filed 2024-08-06 | -$107.39M derived: sum of 3 quarters · filed 2025-02-25 | -$113.18M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | -$59.71M 10-Q · filed 2024-05-07 | -$70.76M derived: sum of 2 quarters · filed 2025-02-25 | -$76.55M derived: sum of 3 quarters · filed 2025-02-25 | -$69.90M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | -$11.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$16.83M derived: sum of 2 quarters · filed 2025-02-25 | -$10.19M derived: sum of 3 quarters · filed 2025-02-25 | -$13.27M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | -$5.79M 10-Q · filed 2023-11-08 | $854.00K derived: sum of 2 quarters · filed 2023-11-08 | -$2.22M 10-Q · filed 2023-11-08 | -$11.58M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-06-30 | $6.64M 10-Q · filed 2023-08-08 | $3.56M 10-Q · filed 2023-08-08 | -$5.79M derived: sum of 3 quarters · filed 2024-03-05 | -$6.10M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2022-03-31 | -$3.08M 10-Q · filed 2023-05-09 | -$12.43M derived: sum of 2 quarters · filed 2024-03-05 | -$12.74M derived: sum of 3 quarters · filed 2024-03-05 | -$8.48M derived: sum of 4 quarters · filed 2024-03-05 | ||||
| 2021-12-31 | -$9.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$9.67M derived: sum of 2 quarters · filed 2024-03-05 | -$5.40M derived: sum of 3 quarters · filed 2024-03-05 | -$8.31M 10-K · filed 2024-03-05 | ||||
| 2021-09-30 | -$313.00K 10-Q · filed 2022-11-03 | $3.95M derived: sum of 2 quarters · filed 2022-11-03 | $1.04M 10-Q · filed 2022-11-03 | $4.74M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-06-30 | $4.27M 10-Q · filed 2022-08-05 | $1.35M 10-Q · filed 2022-08-05 | $5.06M derived: sum of 3 quarters · filed 2023-03-06 | $9.23M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2021-03-31 | -$2.92M 10-Q · filed 2022-05-06 | $789.00K derived: sum of 2 quarters · filed 2023-03-06 | $4.96M derived: sum of 3 quarters · filed 2023-03-06 | -$16.04M derived: sum of 4 quarters · filed 2023-03-06 | ||||
| 2020-12-31 | $3.71M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $7.88M derived: sum of 2 quarters · filed 2023-03-06 | -$13.12M derived: sum of 3 quarters · filed 2023-03-06 | -$6.27M 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | $4.17M 10-Q · filed 2021-11-05 | -$16.82M derived: sum of 2 quarters · filed 2021-11-05 | -$9.97M 10-Q · filed 2021-11-05 | -$5.88M derived: sum of 4 quarters · filed 2021-11-05 | ||||
| 2020-06-30 | -$21.00M 10-Q · filed 2021-08-06 | -$14.15M 10-Q · filed 2021-08-06 | -$10.05M derived: sum of 3 quarters · filed 2021-08-06 | -$28.93M derived: sum of 4 quarters · filed 2021-08-06 | ||||
| 2020-03-31 | $6.85M 10-Q · filed 2021-04-30 | $10.95M derived: sum of 2 quarters · filed 2021-04-30 | -$7.93M derived: sum of 3 quarters · filed 2021-04-30 | -$7.48M derived: sum of 4 quarters · filed 2021-04-30 | ||||
| 2019-12-31 | $4.09M 10-K · filed 2020-02-24 | -$14.79M derived: sum of 2 quarters · filed 2020-11-05 | -$14.34M derived: sum of 3 quarters · filed 2020-11-05 | -$18.78M 10-K · filed 2022-02-25 | ||||
| 2019-09-30 | -$18.88M 10-Q · filed 2020-11-05 | -$18.43M derived: sum of 2 quarters · filed 2020-11-05 | -$22.88M 10-Q · filed 2020-11-05 | -$10.48M derived: sum of 4 quarters · filed 2020-11-05 | ||||
| 2019-06-30 | $451.00K 10-Q · filed 2020-08-06 | -$4.00M 10-Q · filed 2020-08-06 | $8.40M derived: sum of 3 quarters · filed 2020-08-06 | $12.31M derived: sum of 4 quarters · filed 2020-08-06 | ||||
| 2019-03-31 | -$4.45M 10-Q · filed 2020-05-08 | $7.95M derived: sum of 2 quarters · filed 2020-05-08 | $11.86M derived: sum of 3 quarters · filed 2020-05-08 | $17.78M derived: sum of 4 quarters · filed 2020-05-08 | ||||
| 2018-12-31 | $12.40M 10-K · filed 2020-02-24 | $16.31M derived: sum of 2 quarters · filed 2020-02-24 | $22.22M derived: sum of 3 quarters · filed 2020-02-24 | $30.09M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | $3.91M 10-K · filed 2020-02-24 | $9.82M derived: sum of 2 quarters · filed 2020-02-24 | $17.69M 10-Q · filed 2019-10-28 | $17.70M 10-Q · filed 2018-10-29 | $35.55M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2018-06-30 | $5.92M 10-K · filed 2020-02-24 | $7.02M 10-Q · filed 2018-08-06 | $13.79M 10-Q · filed 2019-08-05 | $14.90M 10-Q · filed 2018-08-06 | $31.64M derived: sum of 3 quarters · filed 2020-02-24 | $40.68M derived: sum of 4 quarters · filed 2020-02-24 | ||
| 2018-03-31 | $7.87M 10-K · filed 2020-02-24 | $7.87M 10-Q · filed 2018-04-30 | $25.73M derived: sum of 2 quarters · filed 2020-02-24 | $34.76M derived: sum of 3 quarters · filed 2020-02-24 | $42.76M derived: sum of 4 quarters · filed 2020-02-24 | |||
| 2017-12-31 | $17.86M 10-K · filed 2019-02-25 | $26.89M derived: sum of 2 quarters · filed 2019-02-25 | $34.89M derived: sum of 3 quarters · filed 2019-02-25 | $40.81M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | $9.03M 10-K · filed 2019-02-25 | $17.03M derived: sum of 2 quarters · filed 2019-02-25 | $22.95M 10-Q · filed 2018-10-29 | $30.37M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-06-30 | $8.00M 10-K · filed 2019-02-25 | $13.92M 10-Q · filed 2018-08-06 | $21.33M derived: sum of 3 quarters · filed 2019-02-25 | $30.60M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2017-03-31 | $5.92M 10-K · filed 2019-02-25 | $13.34M derived: sum of 2 quarters · filed 2019-02-25 | $22.61M derived: sum of 3 quarters · filed 2019-02-25 | $19.91M derived: sum of 4 quarters · filed 2019-02-25 | ||||
| 2016-12-31 | $7.42M 10-K · filed 2018-02-26 | $16.69M derived: sum of 2 quarters · filed 2018-02-26 | $13.99M derived: sum of 3 quarters · filed 2018-02-26 | $21.07M 10-K · filed 2019-02-25 | ||||
| 2016-09-30 | $9.27M 10-K · filed 2018-02-26 | $6.58M derived: sum of 2 quarters · filed 2018-02-26 | $13.65M 10-Q · filed 2017-10-30 | $21.03M derived: sum of 4 quarters · filed 2018-02-26 | ||||
| 2016-06-30 | -$2.69M 10-K · filed 2018-02-26 | -$2.64M 10-Q · filed 2016-08-01 | $4.38M 10-Q · filed 2017-08-07 | $4.49M 10-Q · filed 2016-08-01 | $11.76M derived: sum of 3 quarters · filed 2018-02-26 | $15.90M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-03-31 | $7.08M 10-K · filed 2018-02-26 | $7.13M 10-Q · filed 2016-04-28 | $14.46M derived: sum of 2 quarters · filed 2018-02-26 | $18.59M derived: sum of 3 quarters · filed 2018-02-26 | $23.52M derived: sum of 4 quarters · filed 2018-02-26 | |||
| 2015-12-31 | $7.38M 10-K · filed 2017-02-27 | $11.52M derived: sum of 2 quarters · filed 2017-02-27 | $16.45M derived: sum of 3 quarters · filed 2017-02-27 | $9.26M 10-K · filed 2018-02-26 | ||||
| 2015-09-30 | $4.14M 10-K · filed 2017-02-27 | $9.07M derived: sum of 2 quarters · filed 2017-02-27 | $1.88M 10-Q · filed 2016-10-31 | $5.83M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $4.93M 10-K · filed 2017-02-27 | -$2.26M 10-Q · filed 2016-08-01 | $1.69M derived: sum of 3 quarters · filed 2017-02-27 | $8.20M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | -$7.19M 10-K · filed 2017-02-27 | -$3.24M derived: sum of 2 quarters · filed 2017-02-27 | $3.27M derived: sum of 3 quarters · filed 2017-02-27 | $9.97M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $3.95M 10-K · filed 2016-02-29 | $10.46M derived: sum of 2 quarters · filed 2016-02-29 | $17.16M derived: sum of 3 quarters · filed 2016-02-29 | $17.14M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | $6.51M 10-K · filed 2016-02-29 | $13.21M derived: sum of 2 quarters · filed 2016-02-29 | $13.18M 10-Q · filed 2015-11-03 | $3.10M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $6.70M 10-K · filed 2016-02-29 | $6.67M 10-Q · filed 2015-08-04 | -$3.40M derived: sum of 3 quarters · filed 2016-02-29 | -$17.50M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | -$29.00K 10-K · filed 2016-02-29 | $2.46M 10-Q · filed 2014-05-08 | -$10.11M derived: sum of 2 quarters · filed 2016-02-29 | -$24.21M derived: sum of 3 quarters · filed 2016-02-29 | -$17.29M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$10.08M 10-K · filed 2015-04-29 | $6.38M 10-K · filed 2014-03-31 | -$24.18M derived: sum of 2 quarters · filed 2015-04-29 | -$17.26M derived: sum of 3 quarters · filed 2015-04-29 | -$11.19M 10-K · filed 2016-02-29 | -$5.09M 10-K · filed 2014-03-31 | ||
| 2013-09-30 | -$14.10M 10-K · filed 2015-04-29 | -$15.60M 10-Q · filed 2014-03-25 | -$7.18M derived: sum of 2 quarters · filed 2015-04-29 | -$1.11M 10-Q · filed 2015-03-31 | $1.29M 10-Q · filed 2014-03-25 | $25.41M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-06-30 | $6.92M 10-K · filed 2015-04-29 | $8.80M 10-Q · filed 2014-03-24 | $12.99M 10-Q · filed 2015-03-31 | $16.89M 10-Q · filed 2014-03-24 | $39.51M derived: sum of 3 quarters · filed 2015-04-29 | $56.45M derived: sum of 4 quarters · filed 2015-04-29 | ||
| 2013-03-31 | $6.07M 10-K · filed 2015-04-29 | $4.02M 10-Q · filed 2013-05-09 | $32.59M derived: sum of 2 quarters · filed 2015-04-29 | $49.53M derived: sum of 3 quarters · filed 2015-04-29 | $66.15M derived: sum of 4 quarters · filed 2015-04-29 | |||
| 2012-12-31 | $26.52M 10-K/A · filed 2015-03-31 | $25.61M 10-K/A · filed 2014-03-24 | $43.46M derived: sum of 2 quarters · filed 2015-03-31 | $60.08M derived: sum of 3 quarters · filed 2015-03-31 | $74.87M 10-K · filed 2015-04-29 | $89.01M 10-K · filed 2013-03-01 | ||
| 2012-09-30 | $16.94M 10-K/A · filed 2015-03-31 | $21.53M 10-Q · filed 2012-11-02 | $33.56M derived: sum of 2 quarters · filed 2015-03-31 | $51.02M 10-Q · filed 2014-03-25 | $64.53M 10-Q · filed 2012-11-02 | $56.53M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-06-30 | $16.62M 10-K/A · filed 2015-03-31 | $20.57M 10-Q · filed 2012-07-30 | $32.22M 10-Q · filed 2014-03-24 | $43.00M 10-Q · filed 2012-07-30 | $39.59M derived: sum of 3 quarters · filed 2015-03-31 | $60.55M derived: sum of 4 quarters · filed 2015-03-31 | ||
| 2012-03-31 | $14.79M 10-K/A · filed 2015-03-31 | $22.04M 10-Q · filed 2012-05-04 | $22.96M derived: sum of 2 quarters · filed 2015-03-31 | $43.93M derived: sum of 3 quarters · filed 2015-03-31 | $56.29M derived: sum of 4 quarters · filed 2015-03-31 | |||
| 2011-12-31 | $8.17M 10-K/A · filed 2014-03-24 | $29.14M derived: sum of 2 quarters · filed 2014-03-24 | $41.50M derived: sum of 3 quarters · filed 2014-03-24 | $6.61M 10-K/A · filed 2015-03-31 | $32.52M 10-K · filed 2012-02-29 | |||
| 2011-09-30 | $20.97M 10-K/A · filed 2014-03-24 | $23.02M 10-Q · filed 2011-10-31 | $33.33M derived: sum of 2 quarters · filed 2014-03-24 | $15.50M 10-Q · filed 2012-11-02 | $15.53M 10-Q · filed 2011-10-31 | -$8.44M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-06-30 | $12.36M 10-K/A · filed 2014-03-24 | $18.57M 10-Q · filed 2011-08-05 | -$8.10M 10-Q · filed 2012-07-30 | -$7.49M 10-Q · filed 2011-08-05 | -$29.41M derived: sum of 3 quarters · filed 2014-03-24 | -$10.41M derived: sum of 4 quarters · filed 2014-03-24 | ||
| 2011-03-31 | -$35.60M 10-K/A · filed 2014-03-24 | -$26.06M 10-Q · filed 2012-05-04 | -$41.77M derived: sum of 2 quarters · filed 2014-03-24 | -$22.77M derived: sum of 3 quarters · filed 2014-03-24 | -$1.56M derived: sum of 4 quarters · filed 2014-03-24 | |||
| 2010-12-31 | -$6.17M derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-03-24 | $12.83M derived: sum of 2 quarters · filed 2014-03-24 | $34.04M derived: sum of 3 quarters · filed 2014-03-24 | $65.98M 10-K/A · filed 2014-03-24 | $88.99M 10-K · filed 2012-02-29 | |||
| 2010-09-30 | $18.99M 10-Q · filed 2011-10-31 | $40.20M derived: sum of 2 quarters · filed 2011-10-31 | $72.15M 10-Q · filed 2011-10-31 | |||||
| 2010-06-30 | $21.21M 10-Q · filed 2011-08-05 | $53.16M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $63.88M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |